Bakhu enters $600k compliance funding MoU with Phytocyte
Bakhu Holdings Corp. signed a $600,000 non-interest convertible note with Phytocyte to restore compliance. The deal proposes transferring 70% of share capital, signaling significant corporate restructuring.
View filing at SEC.gov →